Intra-tumor Injection of Drug-eluting Microspheres With Multiple Drugs
Recruiting · NCT04770207 · Interventional (participants receive a specific treatment) · Lead sponsor: Second Affiliated Hospital of Guangzhou Medical University
View the official record on ClinicalTrials.gov →Interventions studied
Injection of drug-eluting microspheres with multiple drugs into solid tumors
What this trial is about
To study the safety and clinical effect of injection of drug-eluting microspheres with multiple chemodrug and/or protein drugs into advanced solid tumors.
Who can take part
Age range
18 Years to 99 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 2
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Solid advanced malignant tumors
- Age between18 and 99 years
- Life expectancy is greater than three months
Exclusion criteria
- Benign tumor
- Life expectancy is less than three months
- Serious medical comorbidity
- Others
Where it is running
1 location listed.
- The Second Affiliated Hospital of Guangzhou Medical University - Guangzhou, Guangdong, China